Indeed, we found, overall, higher levels of NAD+-synthesis enzymes NAMPT, NMRK1, and QPRT as well as NADK in primary glioblastomas compared to low-grade gliomas and astrocytes in our and publicly available data, indicating an overall increase in NAD+-biosynthesis in malignant cells. This evidence concerns the gene NADK and glioblastoma.